All Companies
Ticker DRTS
No quarterly filings we can read
You reached the page — here's exactly what DRTS is, and why it's out of scope for now.
What this ticker is
DRTS
Alpha Tau Medical Ltd.
NASDAQ
Healthcare
Biotechnology
Israel
Mkt cap $1.4B
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on developing Alpha DaRT, a targeted alpha-radiation therapy for solid tumors. Alpha DaRT is designed to deliver localized radiation directly within tumor tissue, supporting treatment research across a range of cancers such as skin, oral, pancreatic, prostate, lung, liver, and …
Why we can't analyze it yet
Annual-only filer (20-F/40-F, last annual 2026-03-09, FY end 2025-12-31) — no quarterly XBRL, so an inflection is invisible until the next annual report. Held out under the no-quarterly coverage policy (2026-08-25).
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
no_quarterly